Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

As her fellow correction officers applauded, Shamika Mitchell, 37, walked out of the hospital after six days spent recovering ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Mount Sinai Medical Center marked a significant milestone yesterday with the Topping Out ceremony for the new Irma and Norman Braman Comprehensive Cancer Center, located on its main campus in Miami ...

A judge has ordered a former Cedars-Sinai Medical Center employee to have an arbitrator rather than a jury decide her claims ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Jordan Hannah, 26, who sources say was hired by the FDNY in January of 2022, was busted around 9 a.m. on multiple charges – including first-degree murder – in the April 18, 2021 slaying of ...

Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, ...

A rabbi and a tow truck driver – this sounds like the start of a joke -- but they formed a friendship over a towing in January. On Jan. 8, a tow truck driver from AAA was on a normal call at Baltimore ...

For the doctors and nurses at Palmetto General who have grappled with supply issues, delayed paychecks and service cuts under ...

In the first episode of The Deep End Podcast, we meet Jon Nelson, who shares why he volunteered to get brain implants for his relentless depression.

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...